. 2015 Sep 1;8(9):11629–11634.

Table 2.

Correlation among the number of LNMs, with tumour size, age and gender of patients

		IC	CC	IL	CL	IC+IL
		N=66	N=8	N=47	N=4	N=113
Tumour size	rho	0.29	0.05	0.07	0.77	0.21
Tumour size	P	0.01^*	0.90	0.65	0.22	0.02^*
Patients Age	rho	-0.31	0.17	-0.10	0.25	-0.22
Patients Age	Total p	0.01^*	0.67	0.49	0.74	0.01^*
Gender	rho	-0.04	-0.54	-0.02	0.57	-0.06
Gender	P	0.73	0.16	0.83	0.42	0.51
Tumour size	rho	0.38	0.63	-0.13	n.v.	0.18
Tumour size	P	0.05	0.36	0.62	n.v.	0.23
Patients Age	rho <45	-0.19	0.10	0.11	n.v.	-0.09
Patients Age	P	0.33	0.89	0.68	n.v.	0.54
Gender	rho	-0.05	0.94	-0.16	n.v	-0.11
Gender	P	0.39	0.05	0.55		0.47
Tumour size	rho	0.38	-0.33	0.08	0.86	0.27
Tumour size	P	0.01^*	0.66	0.63	0.33	0.02^*
Patients Age	rho >45	0.004	0.73	-0.08	0.90	0.04
Patients Age	P	0.97	0.26	0.65	1.00	0.73
Gender	rho	-0.19	0.27	-0.04	0.50	-0.15
Gender	P	0.13	0.72	0.81	0.60	0.21

statistically significant (P value<0.05).

rho: Spearman’s correlation coefficient; n.v.: not value; LNM: lymph node metastases; IC group: ipsilateral central; CC group: contralateral central; IL group: ipsilateral lateral; CL group: contralateral lateral.